Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Recruiting · NCT05965479 · Registry updated 2024-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, esophageal disorder, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2024-11-12 | NCT05965479 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Natera, Inc. | 45 |
| University of Southampton | 60 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.